Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
493
-
Total 13F shares, excl. options
-
91M
-
Shares change
-
-351K
-
Total reported value, excl. options
-
$19.9B
-
Value change
-
+$32.5M
-
Put/Call ratio
-
1.96
-
Number of buys
-
237
-
Number of sells
-
-195
-
Price
-
$218.74
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q4 2019
559 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q4 2019.
DEXCOM INC - Common Stock (DXCM) has 493 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91M shares
of 392M outstanding shares and own 23.23% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.47M shares), FMR LLC (7.02M shares), BlackRock Inc. (5.5M shares), BAILLIE GIFFORD & CO (4.82M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.58M shares), MORGAN STANLEY (4.17M shares), JPMORGAN CHASE & CO (3.61M shares), JENNISON ASSOCIATES LLC (3.46M shares), Capital World Investors (3.2M shares), and BROWN ADVISORY INC (2.35M shares).
This table shows the top 493 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.